LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

Boston Scientific Corp.

Închisă

Sector Sănătate

81.59 0.31

Rezumat

Modificarea prețului

24h

Curent

Minim

81.29

Maxim

81.65

Indicatori cheie

By Trading Economics

Venit

-168M

324M

Vânzări

260M

4.1B

P/E

Medie Sector

64.71

103.001

EPS

0.62

Marjă de profit

7.864

Angajați

48,000

EBITDA

-173M

808M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+7.67 upside

Dividende

By Dow Jones

Următoarele câștiguri

24 oct. 2024

Statistici piață

By TradingEconomics

Capitalizare de piață

617M

120B

Deschiderea anterioară

81.28

Închiderea anterioară

81.59

Sentimentul știrilor

By Acuity

30%

70%

56 / 365 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Boston Scientific Corp. Grafic

Știri relevante

18 iun. 2024, 13:23 UTC

Achiziții, Fuziuni, Preluări

Correction to Boston Scientific to Buy Silk Road Article

18 iun. 2024, 11:41 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Silk Road Medical Shares Surge Premarket on Boston Scientific Deal

18 iun. 2024, 11:31 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific to Buy Silk Road Medical for About $1.26 Billion

24 apr. 2024, 11:01 UTC

Câștiguri

Boston Scientific Lifts 2024 Outlook After Strong 1Q

24 iul. 2024, 12:02 UTC

Câștiguri

Boston Scientific Earnings Beat; Medtech Giant Raises Guidance -- IBD

24 iul. 2024, 10:48 UTC

Câștiguri

Boston Scientific Profit Beats Estimates As Cardiovascular Sales Surge -- MarketWatch

24 iul. 2024, 10:47 UTC

Câștiguri

GE Vernova Delivers An Earnings Beat With First Results After Separation, Even As Revenue Misses -- MarketWatch

24 iul. 2024, 10:47 UTC

Câștiguri

Boston Scientific Earnings Beat, Guidance Raised; Medtech Giant Rises -- IBD

24 iul. 2024, 10:33 UTC

Câștiguri

Boston Scientific Sees 3Q Net Sales Growth of About 13%-15% >BSX

24 iul. 2024, 10:32 UTC

Câștiguri

Boston Scientific Sees FY Net Sales Growth of About 13.5%-14.5% >BSX

24 iul. 2024, 10:30 UTC

Câștiguri

Boston Scientific Sees FY EPS $1.34-EPS $1.38 >BSX

24 iul. 2024, 10:30 UTC

Câștiguri

Boston Scientific Sees FY Adj EPS $2.38-Adj EPS $2.42 >BSX

24 iul. 2024, 10:30 UTC

Câștiguri

Boston Scientific 2Q Adj EPS 62c >BSX

24 iul. 2024, 10:30 UTC

Câștiguri

Boston Scientific 2Q EPS 22c >BSX

24 iul. 2024, 10:30 UTC

Câștiguri

Boston Scientific Sees 3Q Adj EPS 57c-Adj EPS 59c >BSX

24 iul. 2024, 10:30 UTC

Câștiguri

Boston Scientific Sees 3Q EPS 36c-EPS 38c >BSX

24 iul. 2024, 10:30 UTC

Câștiguri

Boston Scientific 2Q Sales $4.12B >BSX

18 iun. 2024, 20:22 UTC

Achiziții, Fuziuni, Preluări

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 iun. 2024, 14:25 UTC

Achiziții, Fuziuni, Preluări

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 iun. 2024, 12:54 UTC

Achiziții, Fuziuni, Preluări

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 iun. 2024, 11:33 UTC

Achiziții, Fuziuni, Preluări

Silk Road Medical Stock Soars. It's Being Acquired by Boston Scientific. -- Barrons.com

18 iun. 2024, 11:18 UTC

Achiziții, Fuziuni, Preluări

Silk Road Medical Stock Rallies On Boston Scientific Acquisition Deal -- MarketWatch

18 iun. 2024, 11:03 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific Sees Immaterial Impact to Adjusted EPS In 2024, 2025 >BSX

18 iun. 2024, 11:02 UTC

Achiziții, Fuziuni, Preluări

Silk Road Medical to Be Acquired for $27.50/Share; Closed Monday at $21.67 >SILK BSX

18 iun. 2024, 11:01 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific: Silk Road Medical Deal Reflects Enterprise Value of About $1.16 Billion >BSX SILK

18 iun. 2024, 11:01 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific To Buy Silk Road Medical for $27.50/Share >BSX SILK

18 iun. 2024, 11:00 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific Announces Agreement To Acquire Silk Road Medical, Inc. >BSX SILK

24 apr. 2024, 12:30 UTC

Top știri
Câștiguri

Boston Scientific Stock Rises on More Than Just an Earnings Beat -- Barrons.com

24 apr. 2024, 10:36 UTC

Câștiguri

Boston Scientific Sees 2024 Sales Up 11%-13%, Organic Sales Up 10%-12% >BSX

24 apr. 2024, 10:35 UTC

Câștiguri

Boston Scientific Sees 2Q Sales Up 10.5%-12.5%, Organic Sales Up 10%-12% >BSX

Comparație

Modificare preț

Boston Scientific Corp. Așteptări

Obiectiv de preț

By TipRanks

7.67% sus

Prognoză pe 12 luni

Medie 87.61 USD  7.67%

Maxim 100 USD

Minim 78 USD

În baza a 19 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruBoston Scientific Corp. - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

19 ratings

18

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

79.9 / 81.79Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Bullish Evidence

Termen lung

Weak Bullish Evidence

Sentiment

By Acuity

56 / 365 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Boston Scientific Corp.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.